BioClin Therapeutics Announces Name Change to Rainier Therapeutics

Aura Biosciences Presents Updated Phase 1b/2 Clinical Data for AU-011 at the American Academy of Ophthalmology 2018 Annual Meeting

Galecto Biotech Raises €79 Million in Series C Financing Co-Led by Ysios Capital and OrbiMed to Advance Galectin Inhibitor to Late-Stage Clinical Development

JAMA publishes Phase II recAP data for sepsis-associated Acute Kidney Injury

Data from first in-human clinical trial of SNF472 in haemodialysis patients published in British Journal of Clinical Pharmacology

AELIX Therapeutics and Gilead Sciences Enter into a Clinical Research Collaboration Agreement to Evaluate a Therapeutic Vaccine and TLR7 Agonist Regimen for HIV Cure

KALA PHARMACEUTICALS SUBMITS NEW DRUG APPLICATION TO U.S. FOOD AND DRUG ADMINISTRATION FOR KPI-121 0.25% FOR DRY EYE DISEASE

KALA PHARMACEUTICALS ANNOUNCES PRICING OF PUBLIC OFFERING OF 7,500,000 SHARES OF COMMON STOCK

KALA PHARMACEUTICALS ANNOUNCES FINANCING FROM ATHYRIUM CAPITAL MANAGEMENT TOTALING $110 MILLION

Minoryx Therapeutics raises €21.3M in Series B funding round